Lobe Sciences Ltd. (LOBEF) Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.
Sector: Biotechnology
Industry: Biotechnology
Lobe Sciences Ltd. OTC:LOBEF Healthcare · Biotechnology
Mkt Cap $10.93M
EV -
SI 0.1%
Net Cash/Sh -
CLOSED Prev close $0.0320 +10.81%Close $0.0355 VOL 933 $ Vol $33 RVOL 0.01x
Mkt Cap $10.93M
EV -
VOL 933 sh
$ Vol $33
RVOL 0.01×
SI 0.1%
Net Cash/Sh -
Press Release
Lobe Sciences Appoints Tracy L. Goeken, M.D.
accessnewswire.com • 27d ago Press Release ● Major
Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
accessnewswire.com • 1mo ago Press Release ● Major
Lobe Sciences Announces Proposed Capital Markets Initiatives to Support Planned Growth
accessnewswire.com • 1mo ago Press Release
Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit
accessnewswire.com • 2mo ago Press Release
Lobe Sciences to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
newsfilecorp.com • 2mo ago Press Release ● Critical
Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
accessnewswire.com • 2mo ago Press Release ● Critical
Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
accessnewswire.com • 2mo ago Press Release ● Major
Lobe Sciences Expands Leadership Team with New CFO Appointment
accessnewswire.com • 2mo ago Press Release ● Critical
Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
accessnewswire.com • 2mo ago Press Release ● Major
Lobe Sciences Reports Third Quarter 2026 Financial Results
accessnewswire.com • 2mo ago Press Release ● Critical
Lobe Sciences Ltd. Announces Non-Brokered Private Placement
accessnewswire.com • 3mo ago Press Release
Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
accessnewswire.com • 3mo ago Press Release
Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026
accessnewswire.com • 4mo ago Press Release
Lobe Sciences Announces Proposed Shares for Debt Transaction
accessnewswire.com • 5mo ago Press Release
Lobe Sciences Ltd. Announces Participation in the D.
accessnewswire.com • 6mo ago Press Release
Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
accessnewswire.com • 6mo ago Press Release
Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
accessnewswire.com • 6mo ago Press Release
Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update
accessnewswire.com • 6mo ago